The Food and Drug Administration (FDA) has given a thumbs up to the first-ever treatment for peanut butter allergy in children. The new drug is called AR101 or Palforzia, which increases children’s tolerance level to the small quantity of peanuts. It also lowers down the risk of side effects of accidental exposure. However, it does not treat the allergy caused by the food item. Palforzia has been approved for the children between the age group of 4 to 17 years. It is available in the powder form, which can be sprinkled on the food. It will be sold for $890 per month. Peanut butter can be life threatening in children at times.
As per the officials of the FDA, peanut allergy affects nearly 1 million children in the US. However, the allergy outgrows in only one out of five kids. Peter Marks the Head of FDA’s Biologics Evolution and Research has said that there is no cure for such allergies. People who are allergic to peanuts should avoid exposure; else, it can result in severe and life-threatening reactions. The new drug Palforzia works on immunotherapy. Children are given a small but increasing amount of peanut protein for six months under medical supervision during the treatment. They are advised to take a daily dose of the medicine to be able to stand accidental exposure.
The agency has said that there is a risk of a fatal anaphylactic reaction that is still the same so patients should avoid consuming peanuts. Peanuts are common food allergen in the United States. Dr. Peter Marks said that when Palforzia is used along with peanut avoidance, the drug becomes an FDA approved treatment for preventing the risk of these allergic reactions in kids who are allergic to it. According to the American College of Allergy Asthma and Immunology, more than 2.5 percent of all children are allergic to peanuts in the United States. Peanut allergy is linked with Anaphylaxis, which is potentially a deadly condition. People with such conditions require immediate medical attention. Hive, cramping, indigestion, swelling, dizziness, and even fainting are common symptoms of peanut allergy.
The global heat transfer fluid market is poised to grow at a CAGR of 5.6%…
The Calcium Hypochlorite market is poised for substantial growth, projected to reach around USD 2317.9…
The Sodium Metabisulfite Market is poised for significant growth, with a projected value of USD…
activated alumina market size is expected to be worth around USD 1724 Million by 2033, from USD 1018.9 Million…
The bio fungicides market is poised for significant growth, with projections indicating a valuation of…
The hydrogen generation market is forecasted to see substantial growth, reaching USD 489.2 billion by…
The Hydrogen Peroxide Market, valued at USD 3.2 Billion in 2023, is projected to exhibit…
The global bauxite market exhibited significant value and growth trends over recent years. In 2022,…
The aerogel market has demonstrated significant growth, with its valuation reaching USD 876.5 million in…
biobased disinfectant market size was valued at USD 4.5 Billion and it is estimated to reach USD 8.7 billion…
The Concrete Sealer Market is poised for substantial growth, with projections estimating its value to…
The Ammonium Sulfate Market is poised for significant growth, projected to reach approximately USD 6.1…
The cathode material market, integral to advancements in battery technology, has been valued at USD…
The flat glass market, known for its essential role in various industries, is on a…
The Special Graphite Market, valued at USD 785.5 million in 2022, is projected to reach…
The Black Pellets Market is poised for significant growth, with a projected Compound Annual Growth…
The nanosized alumina market, valued at $3.0 billion in 2022, is expected to grow to…
The global methanol market is on a robust growth trajectory, with projections indicating a rise…
The E-Liquids market is set to experience remarkable growth, with a projected Compound Annual Growth…
The PVC market is anticipated to achieve a substantial valuation of USD 94.7 billion by…